SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-21-001255
Filing Date
2021-10-26
Accepted
2021-10-26 16:18:59
Documents
15
Period of Report
2021-10-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52516018.htm   iXBRL 8-K 30980
2 EXHIBIT 99.1 a52516018ex99_1.htm EX-99.1 205892
3 EXHIBIT 99.2 a52516018ex99_2.htm EX-99.2 62060
7 logo.jpg GRAPHIC 9433
  Complete submission text file 0001157523-21-001255.txt   474032

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA usna-20211026.xsd EX-101.SCH 3914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20211026_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20211026_pre.xml EX-101.PRE 16036
8 EXTRACTED XBRL INSTANCE DOCUMENT a52516018_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 211348784
SIC: 2833 Medicinal Chemicals & Botanical Products